News and Trends 17 May 2023 Scribe and Prevail to accelerate CRISPR-based genetic medicines for neurological and neuromuscular diseases …cause serious neurological and neuromuscular diseases. “We are thrilled to work with the Prevail team to advance potential treatments for patients facing debilitating genetic diseases,” said Benjamin Oakes, chief executive… May 17, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Podcast 15 Mar 2024 Reformulating psychedelics for neurodegenerative diseases …psychiatric diseases. Table of contents About Terran Biosciences The company has built a CNS-focused, tech-enabled drug development platform, and is advancing late-stage assets. These include a neuroimaging software platform (now… March 15, 2024 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2022 European Commission approves Dupixent as first and only targeted prurigo nodularis medicine …major role in multiple related and often co-morbid diseases. These diseases include approved indications for Dupixent, such as atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP) and prurigo nodularis,… December 15, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Sep 2024 Six immunology biotech companies revolutionizing immune treatments in 2024 …course in 2020, changing its name, selecting a new board, and shifting to a new focus of developing drugs to treat immunological diseases with high unmet medical needs. The company… September 19, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 28 May 2025 New weight loss drugs: Biotech’s mission to end obesity …to target new genetic, epigenetic, hormonal, metabolic, and cellular pathways that regulate adipose tissue growth, energy balance, and metabolic health. “These approaches aim to improve tolerability, efficacy, and patient adherence,… May 28, 2025 - 17 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 3 Mar 2023 Orphan drug designation for Laevoroc metabolic immune checkpoint inhibitor …09 is a novel metabolic immune checkpoint inhibitor, for the treatment of patients with hematological malignancies who are diagnosed with a relapse after allogeneic stem cell transplant (SCT). LR 09… March 3, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Podcast 16 Feb 2024 How does AI help drug discovery? …with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases…. February 16, 2024 - 10 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Weekly Roundup 24 Nov 2023 Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA …undisclosed targets for the treatment of other neuromuscular diseases, hence expanding its pipeline. The financing was led by investment company Jeito Capital, and other investors that took part include Novo… November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 May 2024 Eight companies spearheading Philadelphia’s biotech industry …leverage FANA technology in cancer immunotherapy and other therapeutic areas. AUM LifeTech’s pipeline focuses on developing RNA silencing therapies for a variety of genetically defined diseases. The company also has… May 21, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jul 2023 Korro Bio and Frequency Therapeutics to merge …the potential to advance genetic medicines beyond rare genetic diseases into larger patient populations with common diseases. About OPERA Korro Bio’s platform, OPERA (oligonucleotide promoted editing of RNA), builds on… July 18, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Feb 2024 Japan’s ten hottest biotech companies in healthcare …disease and type 2 diabetes. For this reason, the Japanese healthcare authorities are encouraging research into the treatment and prevention of these diseases, in addition to promoting the potential of… February 27, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jan 2023 Hundreds of genetic discoveries from FinnGen study New results from the FinnGen research consortium include previously unknown genetic risk factors for many debilitating diseases. These findings have potential to facilitate the development of new therapies. Since initiation… January 19, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email